Save this technology
close
Save to Existing Project
Save to a New Project
SJ-BRV Antiobesity Immunodrug_SJ BIOMED Inc
Korea Health Industry Development Institute (KHIDI) South Korea flag South Korea
Abstract ID:
SJ-BRV Antiobesity Immunodrug
Contact Yong U Kim
RE:
Participants
You

SJ-BRV is novel therapeutic and prophylactic immunodrug for the treatment and prevention of obesity by controlling lipid metabolism in a stage of storage. The key to the SJ-BRV vaccine is to trick the immune system into making antibodies against self antigens. SJ-BRV works by eliciting antibodies that block the binding of lipids in receptors in the adipose tissue thus preventing lipid storage in the adipose tissue.


- Working on process development on candidate protein SJ-BRV


- Formulation Study in preparation


Preparing non-clinical toxicity study design and clinical design

FEATURED
Last Updated Jun 2016
Technology Type THERAPEUTIC
Phase of Development CLINICAL TRIALS
GOVERNMENT INSTITUTE

Opportunity Contact